Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation?
Gut
.
2020 Mar;69(3):609-610.
doi: 10.1136/gutjnl-2019-318444.
Epub 2019 Feb 26.
Authors
Calum D Moulton
1
,
Christine Norton
2
,
Nick Powell
3
,
Zahra Mohamedali
4
,
Christopher W P Hopkins
5
Affiliations
1
Department of Psychological Medicine, King's College London, London, UK.
2
Florence Nightingale School of Nursing & Midwifery, King's College London, London, UK.
3
Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK.
4
GKT School of Medical Education, King's College London, London, UK.
5
Prospect Park Hospital, Berkshire Healthcare NHS Foundation Trust, Reading, UK.
PMID:
30808645
DOI:
10.1136/gutjnl-2019-318444
No abstract available
Keywords:
epidemiology; inflammatory bowel disease; psychosomatic medicine.
Publication types
Letter
Comment
MeSH terms
Antidepressive Agents
Depression*
Humans
Inflammatory Bowel Diseases*
Risk Factors
Substances
Antidepressive Agents